Elkfork Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$6.82M Buy
135,522
+59,748
+79% +$3M 0.17% 116
2019
Q2
$3.82M Sell
75,774
-42,397
-36% -$2.06M 0.09% 190
2019
Q1
$5.49M Sell
118,171
-13,248
-10% -$671K 0.14% 150
2018
Q4
$6.45M Buy
131,419
+49,918
+61% +$2.84M 0.18% 117
2018
Q3
$5.05M Buy
81,501
+64,235
+372% +$3.91M 0.12% 172
2018
Q2
$930K Hold
17,266
0.02% 361
2018
Q1
$785K Buy
+17,266
New +$740K 0.02% 398
2017
Q4
Sell
-13,656
Closed -$504K 1019
2017
Q3
$504K Buy
13,656
+2,851
+26% +$102K 0.01% 486
2017
Q2
$416K Buy
10,805
+4,047
+60% +$148K 0.01% 529
2017
Q1
$230K Buy
6,758
+1,936
+40% +$63.6K 0.01% 565
2016
Q4
$158K Buy
+4,822
New +$156K 0.01% 619

Other funds holding EHC

Elkfork Partners's EHC Position: Q3 2019 in Review

Elkfork Partners increased its Encompass Health (EHC) stake by 79% in Q3 2019, buying an estimated $3M and bringing the position to 135,522 shares worth $6.82M. The position accounts for 0.17% of the portfolio, ranked #116.

Elkfork Partners first reported a position in EHC in Q4 2016 and has held it in 11 quarters since. 360 funds tracked by Wall St. Rank hold EHC as of Q3 2019.

  • Elkfork Partners held 135,522 shares of Encompass Health worth $6.82M as of Q3 2019.
  • Elkfork Partners bought 59,748 Encompass Health shares in Q3 2019, an estimated $3M.
  • Encompass Health made up 0.17% of Elkfork Partners's portfolio in Q3 2019, its #116 holding.
  • Elkfork Partners first reported a position in Encompass Health in Q4 2016 and has held it in 11 quarters since.
  • 360 funds tracked by Wall St. Rank held Encompass Health as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.